3D QSAR studies of 1,3,4-oxadiazole derivatives as antimycobacterial agents

Iranian Journal of Pharmaceutical Research

Volumn 8, Issue 3, 2009, Pages 163-167

  Jha, Krishna Kant ^a   Samad, Abdul ^c   Kumar, Yatendra ^b   Shaharyar, Mohd ^e   Khosa, Ratanlal ^d   Jain, Endra ^a   Bansal, Sandeep ^d  

^a MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

^b ITS Paramedical College   (India)

^c DJ College of Pharmacy   (India)

^d BIT   (India)

^e HAMDARD UNIVERSITY   (India)

Author keywords

1,3,4 oxadiazole; 3D QSAR; Antimycobacterial activity; KNN MFA

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; HALOGEN; SULFUR;

ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG SCREENING; GENETIC ALGORITHM; MYCOBACTERIUM TUBERCULOSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 73949155951     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. World Health Organization: Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. World Health Organization (1997): WHO/TB/97.229:1-227.
2. Butler D. New fronts in an old war. Nature (2000) 406: 670-672.
3. Gazdic A. Correlation between increased incidence of pulmonary tuberculosis and AIDS Med. Arch. (1998) 52: 207-209.
4. Stepanchikova AV, Lagunin AA, Filimonov DA and Poroikov VV. Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structures. Curr. Med. Chem. (2003) 10: 225-233.
5. Geronikaki A, Deraden JC, Filimonov DA, Garibova TL and Macaev FZ. Computer-aided creation of new effective and safe medicine. J. Med. Chem . Chem. (2004) 47: 2870-2876.
6. Geronikaki A, Babaev E and Dehaen W. Design, synthesis, computational and biological evaluation of new anxiolytics. Bioorg. Med. Chem. (2004) 12: 6559-6568.
7. Oruc E, Rollas S, Kandemirili F, Shvets N and Dimoglo AS. 1,3,4-Thiadiazole derivatives, synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation. J. Med. Chem. (2004) 47: 6760-6767.
8. Collins L and Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high- throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. (1997) 41: 1004-1009.
9. Macaev F, Rusu G, Pogrebnoi S, Nathaly S and Reynolds R. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-antimycobacterial activities. Bioorg. Med. Chem. (2005) 13: 4842-4850.
10. Cramer RD, Patterson DE and Bunce JD. Comparative molecular field analysis (CoMFA). Effect of shape on binding of steroids to carrier proteins J. Am. Chem. Soc. (1998) 110: 5959-5967.
11. Klebe G, Abraham U and Meitzner T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. (1994) 37: 24-30.
12. Ajmani S, Kamalakar J and Kulkarni SA. Three-dimensional QSAR using the k-nearest neighbor method and its interpretation J. Chem. Inf. Model. (2006) 46: 24-31.